Jason White, Ph.D.

Jason White, Ph.D., is currently serving as the Associate Director of Program and Alliance Management at CTMC, a joint venture between Resilience and MD Anderson Cancer Center. In this role, they are responsible for overseeing the operation of the first-of-its-kind cell therapy engine, which combines biopharmaceutical manufacturing technology and cancer innovation. Their goal is to rapidly develop and robustly advance novel scientific breakthroughs into medicines to ultimately end cancer.

Prior to their current position, Dr. White worked as a Scientific Project Director at MD Anderson Cancer Center from 2018 to 2023. Jason also served as a Project Scientist for Antibody-Drug Conjugates and PET Imaging at AstraZeneca from 2016 to 2018.

Dr. White's earlier work experience includes being a Graduate Student Researcher in Biomedical Engineering at the University of California, Davis, where they obtained their PhD. Jason also worked as a Graduate Teaching Assistant during their time at the university.

Before their time at UC Davis, Dr. White worked as a Project Engineer at Siemens Molecular Imaging from 2006 to 2008.

Jason White, Ph.D. completed their education in a chronological order. Jason began their academic journey at Texas A&M University from 1996 to 2001, where they earned a Bachelor's Degree in Mechanical Engineering. In 2008, they pursued higher education at the University of California, Davis, and obtained a Master's Degree in Biomedical Engineering, which they completed in 2011. Continuing their academic path, Jason completed their Doctor of Philosophy (Ph.D.) in Biomedical Engineering at the University of California, Davis from 2011 to 2015. Additionally, in 2013, they also obtained a Certificate of Completion in Entrepreneurship Academy from the University of California, Davis - Graduate School of Management.